A potential strategy to control MAPK4-dependent cancer growth
This study has advanced our understanding of the molecular mechanisms underlying the tumor-promoting activity of MAPK4.
Read More
Targeting MAPK4 may offer a new therapeutic opportunity for TNBC
MAPK4 seems to be involved in promoting triple-negative breast cancer growth and its resistance to certain therapies.
Read More
New evidence supports a cancer-promoting role for enzyme MAPK6
The findings suggest that therapies that interfere with MAPK6 activity may offer an effective cancer treatment approach.
Read More
Targeting MAPK4 emerges as a promising therapy for prostate cancer
Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.
Read More